This study assessed the effectiveness of an antihypertensive treatment algorithm with olmesartan medoxomil as the initial agent. This was a 24-week, open-label trial in patients (N=201 ...

Do not take susp in its dry form. Monitor drugs with a narrow therapeutic index, cyclosporine, glimepiride, glipizide, olmesartan medoxomil, glyburide, levothyroxine, oral contraceptives ...